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1. Introduction 
In eucaryotic cells the enzymes connected with the 
biosynthesis ofhaem are distributed between the mito- 
chondria and the cytosol. The final insertion of ferrous 
iron into protoporphyrin is catalyzed by ferrochela- 
tase, an enzyme reported to be firmly bound to the 
matrix side of the mitochondrial inner membrane [I]. 
It means that iron has to pass across the mitochon- 
drial membranes, where its passage may be regulated 
by specific carriers. 
It has been shown that mitochondria isolated from 
different tissues and species transfer iron to the 
matrix space. Several complexes have been used as 
donor compounds: ferric adenine nucleotide com- 
plexes [2]; ferric/ferrous 8-hydroxyquinoline complex 
[3]; and ferric sucrose complex [4-IO]. However, 
it seemed important to investigate a more physio- 
logical substrate. It has been suggested that transfer- 
rin molecules may enter the cell by the process of 
endocytosis and release its iron at sites on the mito- 
chondria [ 1 l-131. The transferrin-iron complex has 
been used as the donor compound and it has been 
shown that isolated rat liver mitochondria accumulate 
iron from transferrin [ 14,151. The mechanism by 
which isolated mitochondria release iron from trans- 
ferrin is unknown. 
The transferrin-iron complex is extremely stable 
under physiological conditions and no measurable 
iron exchange between the transferrin and the trans- 
ferrin and ferritin was observed [ 161. Transferrin 
binds one molecule of HCOi together with each atom 
of iron [ 171. A number of chelating agents have been 
shown to be effective anion substitutes in the trans- 
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ferrin-iron complex and these compounds facilitate 
the exchange of transferrin-bound carbonate. Most of 
the anions able to substitute for HCO; do not labilize 
transferrin iron, others affect iron binding, too, acceler- 
ing the intermolecular iron exchange [ 181. Recently 
it has been suggested that some organic phosphates 
may play a role in iron release from transferrin or in 
the intracellular transport of iron. ATP, ADPand pyro- 
phosphate accelerate the exchange of carbonate of 
the transferrin-iron-carbonate complex [ 191. GTP, 
2,3-diphosphoglycerate, ATP and ADP produce the 
most rapid exchange of iron between the two types 
of transferrin [20]. The uptake of transferrin-bound 
iron by immature erythroid cells was closely corre- 
lated with the intracellular concentration of ATP 
[21,22]. 
This paper reports the effect of chelating agents 
and phosphate compounds on the uptake of iron 
from transferrin by isolated rat liver mitochondria. 
2. Materials and methods 
2.1. Accumulation of /59Fe]transferrin 
Rat liver mitochondria were prepared in 250 mM 
sucrose containing 10 mM Tris-HCl buffer, pH 7.4, 
at cont. 15.0-20.0 mg protein/ml, essentially as in 
[23]. [59Fe]Transferrin was prepared as in [12]. To 
remove unbound 59Fe, the iron-transferrin solution 
was dialyzed for 24 h against 20 mM NaHCOs. Pro- 
tein was estimated using the biuret test. The mito- 
chondria were incubated at 37°C for 30 min in a 
medium containing 225 mM sucrose, 10 mM Tris-HCl 
buffer, pH 7.4,5 mM MgClz, 10 mM KC1 and 5 mM 
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succinate in vol. 1 ml. Further additions or omissions 
and the concentration of iron and transferrin were as 
shown in the figure legends. After incubation the 
mitochondria were centrifuged in a high speed cen- 
trifuge type 310 (Unipan, Warsaw). The pellet was 
washed twice with ice-cold 250 mM sucrose with 
10 mM Tris-HCl buffer, pH 7.4 and 59Fe radioac- 
tivity was measured in the well-type scintillation 
counter type PT 62 (Polon, Warsaw). All experiments 
were performed in triplicate. 
2.2. Dialysis experiments 
After incubation the samples were dialyzed against 
200 ml 250 mM sucrose adjusted to pH 7.4 at 4°C. 
At the indicated time intervals the sacs were removed, 
rinsed with water and placed in the scintillation coun- 
ter for the determination of radioactivity. In the con- 
trol experiments he mitochondria were omitted from 
the incubation mixture. 
3. Results 
3.1. Effect of EDTA, EGTA, citrate, pyruvate, succi- 
nate and glutathione on the uptake of iron from 
transfei7in 
The concentration ofEDTA and EGTA in the incu- 
bation mixture was from 1OpM to 5 mM. In this range 
the total iron accumulation was inhibited more than 
50% (fig.lA). The concentration of citrate, pyruvate 
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and glutathione in the incubation mixture was from 
0.1-10 mM. As seen in fig.lB, iron accumulation was 
inhibited by citrate, but neither pyruvate nor gluta- 
thione had any effect on the iron uptake. All the 
studies on mitochondrial iron accumulation were per- 
formed with mitochondria respiring on 5 mM succi- 
nate in the absence of Pti Higher concentrations of
succinate gave a slight progressive inhibition of the 
iron uptake (fig.1 C). Iron incorporation was stimu- 
lated by Mg’+(fig.lC). In the standard incubation 
medium (see section 2) 5 mM Mg” was used. 
3.2. Effect of phosphate compounds on the uptake of 
iron from transferrin 
Several phosphate compounds were tested for their 
ability to influence iron accumulation. The concentra- 
tion of phosphate compounds in the incubation mix- 
ture was from 0.1-5 mM. As seen in fig.lD, iron 
accumulation was stimulated by ATP, ADP and PPi; 
AMP had no effect. The most active compound was 
PPb For example 2.5 mM PPi enhanced iron uptake 
by 75%. ATP and ADP were less active and in the 
same concentration stimulated iron accumulation by 
50% and 25%, respectively (fig.lD). Preincubation 
with atractyloside (50 PM) did not abolish the effect 
of ATP (table 1). Atractyloside alone had virtually 
no influence on iron accumulation. #en incubation 
was carried out in the presence both ATP and EDTA 
the ATP-stimulatory effect was abolished and iron 
accumulatiOn was inhibited (table 1). 
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Fig.1. Effect of chelating agents, phosphate compounds and Mg2+on the uptake of iron from [59Fe]transferrin. The final concen- 
trations of iron and transferrin in the reaction mixture were 1.835 PM and 1.125 PM, respectively. Protein concentration was 
1.93 mg/ml. 
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Table 1 
Influence of atractyloside and EDTA on the ATP-stimulatory effect 
Treatment 
ATP (mM) _ 0.1 0.5 1.0 2.5 5.0 
(pmol Fe/ 
mg protein) 
185.5 259.5 293.9 306.3 289.2 256.3 
Treatment 
ATP + atractyloside (50 PM) 
(pmol Fe/ 
protein) mg 
185.7 259.9 284.3 297.8 281.5 237.0 
Treatment 
ATP + EDTA (0.5 mM) 
(pmol Fe/ 
protein) mg 
90.6 89.8 112.3 106.8 103.2 104.9 
3.3. Dialysis experiments 
Experiments were carried out as described in sec- 
tion 2 to see whether the incubation with mitochon- 
aria influenced the removal of iron from [59Fe]trans- 
ferrin by chelating agents (fig.2). The iron-transferrin 
complex could not dialyze through Visking tubing. 
The radioactivity of control bags was decreased to 
90% after 7 days of dialysis in agreement with the 
decay of 59Fe. ATP and ADP had no effect when 
added to the incubation mixture both in the absence 
and in the presence of mitochondria. Different results 
were obtained in the presence of EDTA and citrate. 
It is clear that under the conditions described above 
these chelating agents have the capacity of releasing 
iron from transferrin. When dialysis was carried out 
in the presence of mitochondria the removal of iron 
from transferrin was inhibited (fig.2B). 
Fig.2. The time course of the removal of iron from [59Fe]trans- 
ferrin by various chelating agents. The final concentrations of 
iron and transferrin in the reaction mixture were 1.835 NM 
and 1 .125 PM, respectively. Figure 2 represents results of 
dialysis carried out in the absence of mitochondria (fii.2A) 
and in the presence of mitochondria (fig.2B). Protein concen- 
tration was 2.07 mg/ml. 
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4. Discussion 
The results obtained in the present study support 
the observations that isolated rat liver mitochondria 
accumulate iron from transferrin. The process is mar- 
kedly influenced by chelating agents and phosphate 
compounds. 
Analysis of the influence of the chelating agents 
on iron accumulation reveals two stages to this pro- 
cess: 
chelating agent was inhibited. ATP and ADP have 
relatively low affinities for iron and under the condi- 
tions of dialysis have not the capacity of releasing 
iron, but they can mediate and stimulate the exchange 
of iron between transferrin and mitochondria. The 
ATP-stimulatory effect was abolished by the EDTA 
chelating effect. The results observed for AMP, 
pyruvate and glutathione are consistent with obser- 
vation [20] for exchange of iron between the two 
types of transferrin. 
1. Release of iron from the complex probably after 
interaction of transferrin with an other iron-bind- 
ing molecule. 
2. Incorporation of the released iron into the mito- 
chondria. Acknowledgements 
The inhibitory effect of EDTA, EGTA and citrate 
on iron accumulation can be explained as a chelating 
effect after dissociation of transferrin. These com- 
pounds can bi themselves release iron from trans- 
ferrin by substituting for HCO& but in consideration 
of the short time of incubation, this mechanism seems 
less likely [24]. The stimulation of iron uptake by 
ATP, ADP and PPl supports the hypothesis that cellu- 
lar phosphate compounds may facilitate the release of 
iron from transferrin [20]. The mechanism of the 
action of these compounds i  not clear. It is possible 
that they interact with the transferrin molecule to 
produce a conformational change which allows the 
release of iron. It was found that these compounds 
can not substitute for HCC); in the ternary complex 
[19,20]. In view that atractyloside had not effect the 
adenine nucleotide translocator must not play a role 
in iron accumulation by mitochondria, and iron is 
not transferred in form of a complex with the nucleo- 
tides. 
I wish to thank Professor L. Wojtczak for helpful 
discussions and encouragement and Mrs Renate MichaS 
for expert technical assistance. I am grateful to 
Professor J. Liniecki from the Department of Nuclear 
Medicine and Radiobiology, Medical Academy of 
L,6di, who kindly allowed me to use their scintillation 
counter. This work was supported by research grant 
(11.1) from the Nencki Institute of Experimental 
Biology (Warsaw). 
References 
It can be concluded that the rates of iron exchange 
between transferrin and mitochondria in the presence 
of a chelating agent depend partly upon the affinity 
for iron (steric effects) as well as upon the stability 
constant. EDTA, EGTA and citrate have relatively 
high affinities for iron and form stable complexes 
with the released iron, which were washed out during 
centrifugation. Consistent with this interpretation 
are the results of dialysis experiments. When dialysis 
was carried out in the presence of mitochondria, 
a new equilibrium state was probably established and 
the exchange of iron between transferrin and the 
111 
121 
131 
l41 
151 
161 
171 
181 
191 
(101 
1111 
1121 
Jones, M. S. and Jones, 0. T. G. (1969) Biochem. J. 113, 
507-514. 
Strickland, E. H. and Davis, B. C. (1965) Biqchim. 
Biophys. Acta 104,596-599. 
Cederbaum, A. I. and Wainio, W. W. (1972) J. Biol. 
Chem. 247,4593-4603. 
Romslo, I. and Flatmark, T. (1973) Biochim. Biophys. 
Acta 305,29-40. 
Romslo, I. and Flatmark, T. (1973) Biochim. Biophys. 
Acta 325,38-46. 
Romslo, I. and Flatmark, T. (1974) Biochim. Biophys. 
Acta 347,160-167. 
Romslo, I. (1974) Biochim. Biophys. Acta 357, 3442. 
Romslo, I. (1974) FEBS L&t. 43,144-147. 
Romslo, I. (1975) Biochim. Biophys. Acta 387,69-79. 
Romslo, I. and Flatmark, T. (1975) Biochim. Biophys. 
Acta 387,80-94. 
Morgan, E. H. and Appleton, T. C. (1969) Nature 223, 
1371-1372. 
Martinez-Medellin, J. and Schulman, H. M. (1972) 
Biochim. Biophys. Acta 264,272-284. 
311 
Volume 92, number 2 FEBSLETTERS August 1978 
[ 131 Martinez-Medellin, J., Schulman, H. M., DeMiguel, E. [ 181 Pollack, S., Vanderhoff, G. and Lasky, F. (1977) 
and Benavides, L. (1977) in: Proteins of Iron Meta- Biochim. Biophys. Acta 497,481-487. 
bolism (Brown, E. B., Aisen, P., Fielding, J. and [19] Egyed,A.(1975)Biochim.Biophys.Acta411,349-356. 
Crichton, R. R. eds) pp. 305-310, Grune and Stratton, [20] Morgan, E. H. (1977) Biochim. Biophys. Acta 499, 
New York. 169-177. 
[ 141 Dlvik, R., Prante, P. H., Koller, M. E. and Romslo, I. 
(1976) Stand. I. Clin. Lab. Invest. 36,539-546. 
[ 151 KoIler, M. E., Prante, P. H., Ulvik, R. and Romslo, I. 
(1976) Biochem. Biophys. Res. Commun. 71, 
339-346. 
[ 21 J Egyed, A. (1977) in: Proteins of Iron Metabolism 
(Brown, E. B., A&n, P., Fielding, J. and Crichton, R. R. 
eds) pp. 237-244, Grune and Stratton, New York. 
[ 221 Kailis, S. G. and Morgan,E. H. (1977) Biochim. Biophys. 
Acta 464,389-398. 
[16] Miller, I. P. and Perkins, D. .I. (1969) Eur. J. Biochem. 
10,146-151. 
[ 171 Schlabach, M. R. and Bates, G. W. (1975) J. Biol. Chem. 
250,2182-2188. 
[23] Turska, E. and Turski, W. (1978) Enzyme 23,98-103. 
[ 241 Bates, G. W., Billups, C. and Saltman, P. (1967) J. Biol. 
Chem. 242,2816-2821. 
312 
